World Asthma Day 2021
IMPORTANT BROWSER INFORMATION
This site will not work on Internet Explorer 8. Please use:
Asthma is a chronic lung disease which causes breathing difficulties and affects sufferers to varying degrees, asthma is caused by swelling and inflammation of the bronchial tubes, sometimes in reaction to allergens, exercise, stress or changes in temperature. Asthma is not usually curable but can be controlled to certain extents, depending on how it affects the sufferer. If asthma is controlled then sufferers can live relatively normal lives, although some triggers may have to be avoided.
Asthma is controlled by prevention medication for chronic symptoms and relief medication for flare-ups of asthma symptoms. Education and understanding are keys to effective control of asthma, which can be fatal if not managed properly. World Asthma Day educates and raises awareness of the condition in the hope of relieving suffering and reducing deaths.
The aim of World Asthma Day is to raise awareness, care, and support for those affected by asthma and to provide support and resources for families caring for children with asthma.
Featuring Speakers from National Jewish Health
Michael E. Wechsler, MD, MMSc is a pulmonologist at National Jewish Health, Division of Pulmonary, Critical Care and Sleep Medicine. Dr. Wechsler is also the Director of the Cohen Family Asthma Institute and a Professor in the Department of Medicine. He will be speaking on Biologic Therapies for the Treatment of Severe Asthma.
Linda Rogers, MD is the Associate Professor, Medicine, Pulmonary, Critical Care and Sleep Medicine at Mount Sinai National Jewish Health Respiratory Institute. She will be presenting on COVID 19 and the Asthmatic Patient.
To successfully complete this activity, the required evaluation must completed by Friday, June 18, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This program is designed to incorporate education for both health professionals and patients/caregivers. The health professional track is geared toward primary care, allergists, pulmonary physicians as well as nurse practitioners, respiratory therapists, and physician assistants. The patient/caregiver program will be appropriate for adult patients and caregivers of adult and pediatric patients.
Following the education activity, learners will be able to:
- Examine appropriate treatment of asthma-associated comorbid conditions as part of asthma management.
- Evaluate the role of biomarkers in the identification of specific patient phenotypes towards selection of the most appropriate biologic for an individual patient.
- Evaluate the impact of climate changes and air pollution on the prevalence of asthma in general and on the timing of asthma exacerbations.
Commercial/In Kind Support
This educational activity is supported by an educational grant from Astra Zeneca.
Participants who register for the program will be sent an email with instructions for accessing the zoom webinar.
Using the link provided in the email, participants must 'register' through zoom to access the program (via the zoom platform). Please use the same name as when registering for the activity to help with verifying participation.
The zoom link will be active 60 minutes prior to the start of the program.
Please click here to send an email if you encounter any problems accessing the program.
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined commercial interest entities within the past 12 months. Any conflict of interests have been resolved prior to this educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
Jessica Most, MD-Activity Director
Pamela Monostra RN, AEC
Gurston Nyquist, MD
Raymond Penn, PhD
Jesse Roman, MD
Stephanie Bork, NP
Presenters are required to disclose at the start of their session if their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Thomas Jefferson University designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Nurses will be awarded 5.0 nursing contact hours.
Other Professionals: This educational activity is designated for 5.0 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
The following session qualifies for 1.0 PA Patient Safety and Risk credit: Keynote: Addressing Asthma Health Disparities in 2021.
The following session qualifies for 0.50 Nursing Pharmacology credit: Biologic Therapies for the Treatment of Severe Asthma.
- 5.00 AMA PRA Category 1 Credit™
- 5.00 Attendance
- 5.00 CNE
- 0.50 CNE Pharmacotherapy
- 0.75 Patient Safety
|Profession/ Affiliation||Registration Rate|
|Nurse and Allied Health Professional||$75|
|Jefferson Health (Center City Campus, Methodist, Abington, Aria, Kennedy, Magee Faculty & Staff)||$50|
Jefferson Health Nurse/Other Health Professional
To register online, you must have a CPD @ JeffLearn account.
RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.